Ester peptide compound as well as preparation method and application thereof

A compound and ester peptide technology, applied in the field of biopharmaceuticals, can solve problems such as insensitivity and drug resistance of cancer cells, achieve strong anti-tumor and anti-viral activities, and have good drug development prospects

Active Publication Date: 2021-04-16
ZHEJIANG UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect that this patented method can identify an acidic protein called Porphyrococus (porophilin) was discovered during research on cancer cells by studying bacteria grown at Chainland University Laboratories near Lansingshausen et al., who found it had certain unique properties such as strong anti-tumors or virus replication capabilities. These characteristics make them ideal for developing drugs against tumours like lung carcinoma.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding new chemical entities (chemostats) which can kill cancerous tissue without causing resistence towards other types of therapies like traditional chemotherapeutic agents.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ester peptide compound as well as preparation method and application thereof
  • Ester peptide compound as well as preparation method and application thereof
  • Ester peptide compound as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The preparation method of Jiangxi Peptidecin, the steps are as follows:

[0036] 1. Large-scale fermentation: Streak and revive Lentzea jiangxiensis CGMCC 4.6609 on YMG solid medium. After culturing for 10 days, pick a single colony and inoculate it into TSB liquid medium. After 3 days of cultivation, it was used as seed solution; then the seed solution (0.5mL / dish) was spread onto 200 dishes of YMG solid medium plates, and left to ferment at 30°C for 18 days.

[0037] 2. Obtaining of crude extract: cut the fermented solid medium plate into large bottles, then soak it in ethyl acetate for 12 hours and filter it with filter paper to obtain the ethyl acetate extract (repeat the operation 5 times); combine ethyl acetate The ester extract was then concentrated under reduced pressure to remove ethyl acetate to obtain a crude extract;

[0038] 3. Separation and purification of the compound: Dissolve the crude extract with an appropriate amount of methanol and put it into four

Embodiment 2

[0051] Determination of anti-tumor cell (human colon cancer cell HCT116) activity of Jiangxi Peptides:

[0052] 1. Preparation of the sample solution to be tested: the sample to be tested is the pure product of peptidin A, B and C prepared in the above-mentioned embodiment 1. The above three samples are accurately weighed and dissolved in dimethyl sulfoxide respectively (DMSO) to prepare ganxipeptide A, B and C solutions with a concentration of 5 mM.

[0053] 2. The activity of Peptides A, B and C on anti-tumor cells (human colon cancer cell line HCT116) was measured by cck8 assay. Experimental steps include:

[0054] (1) Cell culture. HCT116 cells were cultured with medium containing 1640+10% FBS+100x double antibody.

[0055] (2) Plank. Inoculate 28,000 / mL cell suspension in a 96-well plate, and add 200 μL / well of sterile PBS to the surrounding wells to prevent the evaporation of medium water. Incubate for 24 h in a humid 37°C incubator to allow the cells to adhere to

Embodiment 3

[0065] Determination of HIV Reverse Transcriptase Inhibitory Activity of Jiangxi Peptides:

[0066] 1. Preparation of the sample solution to be tested: the sample to be tested is the pure product of peptidin A, B and C prepared in the above-mentioned embodiment 1. The above three samples are accurately weighed and dissolved in dimethyl sulfoxide respectively (DMSO) to prepare ganxipeptide A, B and C solutions with a concentration of 5 mM. Then dilute with DMSO in turn to obtain jangsiopeptide A and B solutions with concentrations of 1000 μM, 300 μM, 120 μM, 60 μM, 24 μM, 8 μM, 3 μM, 1.2 μM, and 600 μM, 200 μM, 60 μM, 30 μM, 9 μM, 3 μM , 1.2μM, 0.6μM Jiangxipeptide C solution.

[0067] 2. Inhibition test of Jiangxi Peptides on HIV reverse transcriptase activity in vitro: The inhibitory activity of Jiangxi Peptides was measured using the HIV Reverse Transcriptase Activity Assay Kit purchased from Sigma-Aldrich Company (Sigma-Aldrich product number: 11468120910) conduct.

[0068]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an ester peptide compound as well as a preparation method and an application thereof, and belongs to the technical field of biological pharmacy. According to the present invention, the ester peptide compound having the new structure is separated from the fermentation product of the Lentziae jiangxiensis with the preservation number of CGMCC 4.6609, wherein the structural formula is represented by the formula (I) (as shown in the description); the compound has strong anti-tumor and anti-virus activity, and has a good drug development prospect.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products